Glen Mills, PA, United States of America

Alagarsamy Srinivisan

This inventor holds 2 USPTO granted patents. Top assignee: Thomas Jefferson University. Active years: 2001-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alagarsamy Srinivisan. Retrieved from https://idiyas.com/inventor/alagarsamy-srinivisan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 50.0

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2001-2002

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Alagarsamy Srinivisan: Innovator in Chimeric Viral Proteins

Introduction

Alagarsamy Srinivisan is a notable inventor based in Glen Mills, Pennsylvania. He has made significant contributions to the field of therapeutic agents through his innovative work on chimeric viral proteins. With a total of two patents to his name, Srinivisan is recognized for his advancements in biotechnology.

Latest Patents

Srinivisan's latest patents focus on chimeric viral proteins and nucleic acid constructs that code for them. These inventions are particularly useful as therapeutic agents, showcasing his commitment to developing solutions that can have a positive impact on health and medicine.

Career Highlights

Srinivisan is affiliated with Thomas Jefferson University, where he continues to engage in research and development. His work at the university allows him to collaborate with other experts in the field and contribute to groundbreaking discoveries.

Collaborations

One of his notable collaborators is Hilary Koprowski, a respected figure in the field of virology. Their partnership exemplifies the importance of teamwork in advancing scientific research and innovation.

Conclusion

Alagarsamy Srinivisan's contributions to the field of chimeric viral proteins highlight his role as an influential inventor. His work not only advances scientific knowledge but also holds promise for future therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…